关于
  • English
  • About
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
    • Proprietary Platform Technology
    • About TFChem
  • Programs
    • Pipeline
      • Antiviral
    • Skincare – Dark Spot Correction
    • Skincare – GlycoProteMim™
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
    • AGM
  • Contact
  • Careers

November 17th, 2009

Sirona Biochem Says New Results From Big Pharma Shows Why SGLT2 Sugar Blockers Are A Major Opportunity In Fighting Diabetes.

November 12th, 2009

Sirona Biochem Ceo Says Diabetes Will Have ‘Profound Consequences’ For Canada As The Epidemic Strikes More Young People.

November 5th, 2009

One Of Canada’s Leading Obesity Scientists Joins Sirona Biochem’s Scientific Advisory Board.

November 3rd, 2009

One Of Canada’s Leading Biotech Pioneers Joins Sirona Biochem’s Scientific Advisory Board.

October 13th, 2009

Sirona Biochem Says New Obesity Data Shows It’s On The Right Path

  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 44
  • Next Page »

Archives

  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
555 Burrard St.
Vancouver, B.C., Canada,V7X1M8

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading